Can the 4 Medical Device Stocks Hit Targets This Earnings Season?
Glaukos Announces the Release of its 2023 Sustainability Report
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.